Product Code: 978-1-68038-407-9
Smart Healthcare Market Growth & Trends:
The global smart healthcare market size is estimated to reach USD 385.28 billion by 2030, registering a CAGR of 12.51% from 2025 to 2030, according to a new report by Grand View Research, Inc. The COVID-19 pandemic is likely to boost the market growth as these solutions help healthcare professionals to connect effectively with their patients and offer quality treatment. Owing to social distancing, remote patient monitoring, and virtual healthcare delivery is gaining momentum. For instance, the U.K. has introduced free virtual consultation during the coronavirus crisis. In April 2020, doctorinthehouse.net, a not-for-profit online healthcare service in the U.K. launched a platform in collaboration with volunteers amongst doctors, pharmacists, and specialist nurses aiming to schedule 25,000 online appointments and supply 100,000 online assessments for over 200 at-home clinicians. Such initiatives are expected to drive the market ahead.
Operating costs are mainly governed by production costs, inventory storage costs, manufacturing overhead costs, wages, energy costs, and logistical costs. Poor inventory control is a major issue faced by companies that leads to substantial operating losses. There is an increasing demand for RFID kanban systems to control their inventory costs. RFID kanban systems owing to associated benefits such as reduction in manpower, higher efficiency, and cost-effectiveness is anticipated drive traction over the forecast period.
Technological advancements are rapidly transforming the market for smart healthcare. Some of the major market players such as IBM, Cisco, Given Imaging, Inc., Olympus Corporation, Logi-Tag, Brooks Automation, Stanley Innerspace, GE Healthcare, and others account for a substantial market share, owing to their extensive product offerings. Key players are focusing on expanding their current portfolio as in March 2020, Siemens Healthineers launched Teamplay digital health platform. It is aimed to enable digital healthcare transformation and eases quick access to clinical and operational solutions. Also, in June 2019, Intel introduced Network And Custom Logic Group it is a broad portfolio of products for Artificial Intelligence (AI) and 5G cloud. This is aimed to broaden the horizons of healthcare applications.
Smart Healthcare Market Report Highlights:
- Based on product type, the telemedicine segment held the largest revenue share of 38.56% in 2024, attributed to the increasing demand for remote healthcare services, especially post-pandemic.
- Based on product type, the RFID Kanban Systems segment is expected to grow at the fastest CAGR during the forecast period, driven by the need for real-time inventory tracking, reduction in stock-outs and overstocking, and improved medication expiration management.
- Based on end-use, the hospitals segment held the largest revenue share of the smart healthcare industry in 2024, due to the increasing demand for advanced technologies to improve patient care, operational efficiency, and cost reduction.
- The home care settings segment is expected to grow at the fastest CAGR in the market, driven by an aging population, increased chronic disease prevalence, and a preference for in-home care.
- North America smart healthcare market dominated the global industry and accounted for a revenue share of over 36.85% in 2024, attributed to favorable government policies supporting digital health deployment, accessible infrastructure, and high digital literacy.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product Type
- 1.2.2. End Use
- 1.2.3. Regional scope
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product Type Outlook
- 2.2.2. End Use Outlook
- 2.2.3. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Smart Healthcare Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising adoption of mHealth
- 3.2.1.2. Supportive government programs
- 3.2.1.3. Technological advancements in medical devices
- 3.2.1.4. Integration of AI and big data analytics
- 3.2.1.5. Emphasis on data-driven healthcare and electronic health records (EHRs)
- 3.2.2. Market restraint analysis
- 3.2.2.1. High initial investment and infrastructure costs
- 3.2.2.2. Data privacy and security concerns
- 3.2.3. Market opportunity analysis
- 3.2.4. Market challenges analysis
- 3.3. Smart Healthcare Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Environmental landscape
- 3.3.2.5. Legal Landscape
- 3.4. Covid-19 Impact
- 3.5. Case Study & Insights
Chapter 4. Smart Healthcare Market: Product Type Estimates & Trend Analysis
- 4.1. Global Smart Healthcare Market: Product Type Dashboard
- 4.2. Product Type Market Share Analysis, 2024 & 2030
- 4.3. Smart Healthcare Market: By Product Type, 2018 to 2030
- 4.4. RFID Kanban Systems
- 4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. RFID Smart Cabinets
- 4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Electronic Health Records (EHR)
- 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.2. Web-based HER
- 4.6.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6.3. Client-server Based HER
- 4.6.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7. Telemedicine
- 4.7.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7.2. Hardware
- 4.7.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7.3. Software
- 4.7.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.7.4. Others
- 4.7.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8. mHealth
- 4.8.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8.2. Monitoring Services
- 4.8.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8.3. Diagnosis Services
- 4.8.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8.4. Healthcare Systems Strengthening
- 4.8.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.8.5. Others
- 4.8.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.9. Smart Pills
- 4.9.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.10. Smart Syringes
- 4.10.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Smart Healthcare Market: End Use Estimates & Trend Analysis
- 5.1. Global Smart Healthcare Market: End Use Dashboard
- 5.2. End Use Market Share Analysis, 2024 & 2030
- 5.3. Smart Healthcare Market: By End Use, 2018 to 2030
- 5.4. Hospitals
- 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Home Care Settings
- 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Others
- 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Smart Healthcare Market: Regional Estimates & Trend Analysis by product type, and end use
- 6.1. Regional Dashboard
- 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
- 6.3. North America
- 6.3.1. U.S.
- 6.3.1.1. Key country dynamics
- 6.3.1.2. Regulatory framework
- 6.3.1.3. Competitive scenario
- 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.2. Canada
- 6.3.2.1. Key country dynamics
- 6.3.2.2. Regulatory framework
- 6.3.2.3. Competitive scenario
- 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 6.3.3. Mexico
- 6.3.3.1. Key country dynamics
- 6.3.3.2. Regulatory framework
- 6.3.3.3. Competitive scenario
- 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4. Europe
- 6.4.1. UK
- 6.4.1.1. Key country dynamics
- 6.4.1.2. Regulatory framework
- 6.4.1.3. Competitive scenario
- 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.2. Germany
- 6.4.2.1. Key country dynamics
- 6.4.2.2. Regulatory framework
- 6.4.2.3. Competitive scenario
- 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. France
- 6.4.3.1. Key country dynamics
- 6.4.3.2. Regulatory framework
- 6.4.3.3. Competitive scenario
- 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.4. Italy
- 6.4.4.1. Key country dynamics
- 6.4.4.2. Regulatory framework
- 6.4.4.3. Competitive scenario
- 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.5. Spain
- 6.4.5.1. Key country dynamics
- 6.4.5.2. Regulatory framework
- 6.4.5.3. Competitive scenario
- 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.6. Denmark
- 6.4.6.1. Key country dynamics
- 6.4.6.2. Regulatory framework
- 6.4.6.3. Competitive scenario
- 6.4.6.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.7. Sweden
- 6.4.7.1. Key country dynamics
- 6.4.7.2. Regulatory framework
- 6.4.7.3. Competitive scenario
- 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.8. Norway
- 6.4.8.1. Key country dynamics
- 6.4.8.2. Regulatory framework
- 6.4.8.3. Competitive scenario
- 6.4.8.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Asia Pacific
- 6.5.1. Japan
- 6.5.1.1. Key country dynamics
- 6.5.1.2. Regulatory framework
- 6.5.1.3. Competitive scenario
- 6.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.2. China
- 6.5.2.1. Key country dynamics
- 6.5.2.2. Regulatory framework
- 6.5.2.3. Competitive scenario
- 6.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.3. India
- 6.5.3.1. Key country dynamics
- 6.5.3.2. Regulatory framework
- 6.5.3.3. Competitive scenario
- 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.4. South Korea
- 6.5.4.1. Key country dynamics
- 6.5.4.2. Regulatory framework
- 6.5.4.3. Competitive scenario
- 6.5.4.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.5. Thailand
- 6.5.5.1. Key country dynamics
- 6.5.5.2. Regulatory framework
- 6.5.5.3. Competitive scenario
- 6.5.5.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5.6. Australia
- 6.5.6.1. Key country dynamics
- 6.5.6.2. Regulatory framework
- 6.5.6.3. Competitive scenario
- 6.5.6.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. Latin America
- 6.6.1. Brazil
- 6.6.1.1. Key country dynamics
- 6.6.1.2. Regulatory framework
- 6.6.1.3. Competitive scenario
- 6.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6.2. Argentina
- 6.6.2.1. Key country dynamics
- 6.6.2.2. Regulatory framework
- 6.6.2.3. Competitive scenario
- 6.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. MEA
- 6.7.1. South Africa
- 6.7.1.1. Key country dynamics
- 6.7.1.2. Regulatory framework
- 6.7.1.3. Competitive scenario
- 6.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.2. Saudi Arabia
- 6.7.2.1. Key country dynamics
- 6.7.2.2. Regulatory framework
- 6.7.2.3. Competitive scenario
- 6.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.3. UAE
- 6.7.3.1. Key country dynamics
- 6.7.3.2. Regulatory framework
- 6.7.3.3. Competitive scenario
- 6.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7.4. Kuwait
- 6.7.4.1. Key country dynamics
- 6.7.4.2. Regulatory framework
- 6.7.4.3. Competitive scenario
- 6.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Competitive Landscape
- 7.1. Company/Competition Categorization
- 7.2. Company Market Share Analysis, 2024
- 7.3. Company Heat Map Analysis
- 7.4. Company Profiles
- 7.4.1. AirStrip Technologies Inc.
- 7.4.1.1. Overview
- 7.4.1.2. Financial performance
- 7.4.1.3. Product benchmarking
- 7.4.1.4. Strategic initiatives
- 7.4.2. Veradigm LLC
- 7.4.2.1. Overview
- 7.4.2.2. Financial performance
- 7.4.2.3. Product benchmarking
- 7.4.2.4. Strategic initiatives
- 7.4.3. Apple Inc.
- 7.4.3.1. Overview
- 7.4.3.2. Financial performance
- 7.4.3.3. Product benchmarking
- 7.4.3.4. Strategic initiatives
- 7.4.4. AT&T Inc.
- 7.4.4.1. Overview
- 7.4.4.2. Financial performance
- 7.4.4.3. Product benchmarking
- 7.4.4.4. Strategic initiatives
- 7.4.5. BROOKS AUTOMATION
- 7.4.5.1. Overview
- 7.4.5.2. Financial performance
- 7.4.5.3. Product benchmarking
- 7.4.5.4. Strategic initiatives
- 7.4.6. Oracle (Cerner Corporation)
- 7.4.6.1. Overview
- 7.4.6.2. Financial performance
- 7.4.6.3. Product benchmarking
- 7.4.6.4. Strategic initiatives
- 7.4.7. Cisco
- 7.4.7.1. Overview
- 7.4.7.2. Financial performance
- 7.4.7.3. Product benchmarking
- 7.4.7.4. Strategic initiatives
- 7.4.8. GE Healthcare
- 7.4.8.1. Overview
- 7.4.8.2. Financial performance
- 7.4.8.3. Product benchmarking
- 7.4.8.4. Strategic initiatives
- 7.4.9. Medtronic
- 7.4.9.1. Overview
- 7.4.9.2. Financial performance
- 7.4.9.3. Product benchmarking
- 7.4.9.4. Strategic initiatives
- 7.4.10. Hurst Green Plastics Ltd.
- 7.4.10.1. Overview
- 7.4.10.2. Financial performance
- 7.4.10.3. Product benchmarking
- 7.4.10.4. Strategic initiatives
- 7.4.11. IBM
- 7.4.11.1. Overview
- 7.4.11.2. Financial performance
- 7.4.11.3. Product benchmarking
- 7.4.11.4. Strategic initiatives
- 7.4.12. Logi-Tag
- 7.4.12.1. Overview
- 7.4.12.2. Financial performance
- 7.4.12.3. Product benchmarking
- 7.4.12.4. Strategic initiatives
- 7.4.13. McKesson Corporation
- 7.4.13.1. Overview
- 7.4.13.2. Financial performance
- 7.4.13.3. Product benchmarking
- 7.4.13.4. Strategic initiatives
- 7.4.14. Olympus Corporation
- 7.4.14.1. Overview
- 7.4.14.2. Financial performance
- 7.4.14.3. Product benchmarking
- 7.4.14.4. Strategic initiatives
- 7.4.15. Pepperl&Fuchs Pvt. Ltd.
- 7.4.15.1. Overview
- 7.4.15.2. Financial performance
- 7.4.15.3. Product benchmarking
- 7.4.15.4. Strategic initiatives
- 7.4.16. SAMSUNG
- 7.4.16.1. Overview
- 7.4.16.2. Financial performance
- 7.4.16.3. Product benchmarking
- 7.4.16.4. Strategic initiatives
- 7.4.17. Siemens Medical Solutions
- 7.4.17.1. Overview
- 7.4.17.2. Financial performance
- 7.4.17.3. Product benchmarking
- 7.4.17.4. Strategic initiatives
- 7.4.18. Solstice Medical LLC
- 7.4.18.1. Overview
- 7.4.18.2. Financial performance
- 7.4.18.3. Product benchmarking
- 7.4.18.4. Strategic initiatives
- 7.4.19. InnerSpace (Acquired by Solaire Medical)
- 7.4.19.1. Overview
- 7.4.19.2. Financial performance
- 7.4.19.3. Product benchmarking
- 7.4.19.4. Strategic initiatives
- 7.4.20. Bollhoff Group
- 7.4.20.1. Overview
- 7.4.20.2. Financial performance
- 7.4.20.3. Product benchmarking
- 7.4.20.4. Strategic initiatives
- 7.4.21. Adolf Wurth GmbH & Co. KG
- 7.4.21.1. Overview
- 7.4.21.2. Financial performance
- 7.4.21.3. Product benchmarking
- 7.4.21.4. Strategic initiatives